David Snow - Teladoc Independent Chairman of the Board

4LL Stock  EUR 9.02  0.34  3.92%   

Chairman

Mr. David B. Snow, Jr., is an Independent Chairman of the Board of the TELADOC, INC. since December 2014. He became a member of our Board in February 2014 he became chairman of our board in December 2014. Since February 2014, Mr. Snow has served as Chairman and Chief Executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to doctor and hospital organizations entering riskbased reimbursement arrangements with insurers. Until April 2012, Mr. Snow was Chairman and Chief Executive Officer of Medco Health Solutions, Inc., a leading pharmacy benefit manager. His current board service includes CareCentrix and Pitney Bowes, Inc. . He formerly served as a director of Medco Health Solutions, Inc. In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies, including WellChoice and Oxford Health Plans since 2014.
Age 64
Tenure 10 years
Phone203 635 2002
Webhttps://www.teladochealth.com
Snow earned a B.S. in Economics from Bates College and a Master’s Degree in Health Care Administration from Duke University. Our Board has concluded that Mr. Snow should serve as a director because of his broad experience in the healthcare industry and his significant core business skills, including financial and strategic planning.

Teladoc Management Efficiency

The company has return on total asset (ROA) of (0.0129) % which means that it has lost $0.0129 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4885) %, meaning that it generated substantial loss on money invested by shareholders. Teladoc's management efficiency ratios could be used to measure how well Teladoc manages its routine affairs as well as how well it operates its assets and liabilities.
Teladoc has accumulated 1.54 B in total debt with debt to equity ratio (D/E) of 0.09, which may suggest the company is not taking enough advantage from borrowing. Teladoc has a current ratio of 3.88, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Teladoc until it has trouble settling it off, either with new capital or with free cash flow. So, Teladoc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Teladoc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Teladoc to invest in growth at high rates of return. When we think about Teladoc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CHAIRMAN Age

John Stuelpnagel10X GENOMICS DL
61
Frank WilliamsEvolent Health
57
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOC HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3652 people. Teladoc (4LL) is traded on Frankfurt Exchange in Germany and employs 37 people.

Management Performance

Teladoc Leadership Team

Elected by the shareholders, the Teladoc's board of directors comprises two types of representatives: Teladoc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Teladoc. The board's role is to monitor Teladoc's management team and ensure that shareholders' interests are well served. Teladoc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Teladoc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael Goldstein, Independent Director
Mike Waters, Chief Officer
Andrew Turitz, Senior Vice President of Business Development
Catherine Jacobson, Independent Director
Sandra Fenwick, Director
Michelle Bucaria, Chief Human Resource Officer
Christopher Bischoff, Director
David Shedlarz, Independent Director
William Frist, Independent Director
Mala Murthy, Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Controller
Mark Smith, Independent Director
David Snow, Independent Chairman of the Board
David Sides, Chief Operating Officer
Richard Napolitano, Chief VP
Thomas McKinley, Independent Director
Christopher Caridi, Senior Vice President Chief Accounting Officer, Controller
Karen Daniel, Director
Lewis Levy, Chief Medical Officer
Claus Jensen, Chief Officer
Adam Vandervoort, Chief Legal Officer and Secretary
Gabriel Cappucci, Senior Vice President Chief Accounting Officer, Controller
Kenneth Paulus, Independent Director
Stephanie Verstraete, Chief Marketing Officer
George Brooks, CoFounder
Hemant Taneja, Director
Glen Tullman, Director
Helen Darling, Independent Director
CPA CFA, VP Relations
Jason Gorevic, Chief Executive Officer, Director
Courtney McLeod, Director Communication

Teladoc Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Teladoc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Teladoc Stock

When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Teladoc Stock please use our How to Invest in Teladoc guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.